RADIOMETABOLIC THERAPY SERVICE
Director: Dr Matteo Salgarello
Coordinator: Lenny Agostinelli
ABOUT US
The Radiometabolic Therapy Service carries out treatment, mainly of tumoral diseases, with radiopharmaceuticals administered by mouth or intravenous. Some radiopharmaceuticals need a complex process of chemical synthesis that in Negrar is carried out in the next Radiopharmacy, purchasing from outside only the radioactive element.
WHERE
CONTACTS
THE STAYS
The Service is equipped with a protect stay, composed of two rooms for a total of four beds. Every room has 60 cm wide walls and controlled management system for sewage to eliminate radioactivity released into the sewer system. During the hospital stay (from 2 to 4 days) the patients are video-monitored 24-hours a day by health personnel and may have television, wireless connection, telephone and also an IPAD to minimize contacts with personnel and make the stay in “isolation” less stressful.
ACTIVITY
The Radiometabolic Therapy Service carries out the following treatments:
- Thyroid differentiated tumors with Iodine 131
- Bone metastases in hormone-resistant prostate cancer with Radium 223
- Hyperthyroidism with Iodine 131
- Neuroendocrine tumors of pancreas, stomach and intestine with Lutetium (177Lu) oxodotreotide (business name Lutathera)